Aldactazine

Quick links to important sections

Aldactazine

Method of action: Diuretic

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aldactazine

Quick Facts

Property Description
Active Ingredients Spironolactone, Altizide
Form Oral Tablet
Pharmacological Class Diuretic and Antihypertensive combination
General Purpose Managing fluid balance and high blood pressure
Origin Synthetic organic compounds

Aldactazine: Classification and Identity

Aldactazine is a prescription-only fixed-dose combination medication administered as an oral tablet, placing it within the pharmacological group of diuretic and antihypertensive combinations. The preparation is synthetic, pairing two compounds with distinct actions. The spironolactone component is classified as an antimineralocorticoid and potassium-sparing agent, reflecting its specific physiological action. This formulation is typically positioned for adult patients requiring dual-action therapy to manage complex fluid or pressure issues.

Active Ingredients and Compound Design

The composition features two active ingredients: Spironolactone and Altizide. This design pairs the fluid-removing capabilities of Altizide, a thiazide-like diuretic, with the potassium-conserving action of Spironolactone, which operates as an aldosterone receptor antagonist. The rationale for combining agents like these is to minimize the risk of electrolyte imbalance often associated with single-agent diuretics, a recognized approach in hypertension management. Consequently, the combination is designed for enhanced therapeutic balance.

General Purpose of the Combined Action

The core general purpose of Aldactazine is to support cardiovascular health by providing a balanced, synergistic diuretic effect. The medication’s dual mechanism results in the sustained removal of excess salt and water while simultaneously ensuring necessary potassium retention. This action is fundamental to relieving symptoms associated with abnormal fluid accumulation (edema) and contributes to the long-term control of high blood pressure, addressing situations where a balanced diuretic response is necessary.

What side effects are possible with Aldactazine?

Possible side effects and safety information

Official regulatory documents classify adverse reactions to Aldactazine (Spironolactone/Altizide) based on frequency and the affected body system, maintaining a focus strictly on documented safety characteristics.

Adverse Reaction Classification

Electrolyte imbalances are a primary focus, with Hyperkalemia (elevated potassium levels) listed as a Very Common reaction in official labeling, primarily due to the Spironolactone component. Other side effects are classified as Common, including dizziness, nausea, rash, pruritus, muscle spasms, and gynecomastia (in males).

Adverse reactions are formally grouped by System-Organ Class (SOC) in regulatory texts, detailing effects across various systems. These include:

  • Metabolism and Nutrition Disorders: Highlighting electrolyte imbalances like hyperkalemia and hyponatremia.
  • Reproductive System and Breast Disorders: Documenting effects such as gynecomastia and menstrual disorders.
  • Nervous System Disorders: Including common effects such as dizziness, confusion, and headache.
  • Skin and Subcutaneous Tissue Disorders: Noting reactions like rash, pruritus, and, in rare instances, severe conditions such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

Serious Safety Considerations

Serious adverse reactions documented in regulatory sources include the critical risk of Severe Hyperkalemia and Acute Kidney Injury. The thiazide component carries a rare, documented risk of serious ocular events, including Acute Angle-Closure Glaucoma.

Official labeling defines specific safety constraints. The medication is contraindicated in conditions such as Anuria, Severe Renal Impairment (eGFR < 30 mL/min), Addison's Disease, or pre-existing Hyperkalemia. Furthermore, safety information notes that the development of certain effects, such as gynecomastia, is related to both the dosage level and the duration of therapy. This structure ensures that the risk profile is systematically defined according to established regulatory standards.

Overdose and Emergency Response

Overdose and When to Seek Help

The following information on Aldactazine overdose is strictly based on data documented in authoritative government regulatory sources, such as official prescribing information.

Documented Overdose Signs and Symptoms

Acute overdosage, often related to the spironolactone component, may present with non-specific signs. The most commonly reported clinical manifestations include:

  • Neurological: Drowsiness and mental confusion.
  • Gastrointestinal: Nausea, vomiting, or diarrhea.
  • Integumentary: Maculopapular or erythematous rash.

Serious Outcomes and Specific Risks

The most serious documented complications of overdosage involve electrolyte imbalance, specifically hyperkalemia (abnormally high potassium levels) or hyponatremia (abnormally low sodium levels). While these imbalances are considered unlikely to result from acute, single-dose overdosage alone, the risk of hyperkalemia is elevated in patients with impaired renal function or severe liver disease.

In rare cases, acute overdosage in individuals with pre-existing severe liver disease has been associated with the potential for hepatic coma.

Required Emergency Action

Immediate medical attention is required in the event of an overdosage. Patients or caregivers should contact a local Poison Control Center or seek emergency medical help right away.

No specific antidote is available for Aldactazine overdose. Management is supportive and aimed at maintaining vital functions, hydration, and restoring electrolyte balance. This often includes supportive measures to manage hyperkalemia, such as withdrawal of the medication and procedures to reduce serum potassium levels.

Therapeutic Uses of Aldactazine

What Aldactazine Treats: Main Uses and Benefits

Long-Term Management of High Blood Pressure

The medication is applied in the context of essential hypertension to help support the management of elevated blood pressure levels. The primary therapeutic benefit is to contribute to cardiovascular support by helping to ease symptoms related to systemic imbalance. This supportive therapeutic approach may assist in easing the systemic burden on the cardiovascular system, which supports overall cardiovascular well-being.


Relief from Chronic Fluid Accumulation (Edema)

Aldactazine is commonly used to help with fluid retention and symptoms that create noticeable physiological strain, such as edema associated with congestive heart failure, cirrhosis of the liver (ascites), and nephrotic syndrome. Quick Fact: This combination is relevant for managing symptom clusters that may become intense or disruptive. By supporting the reduction of excess salt and water, the medication may assist in easing the impact of swelling and fluid congestion. This process may assist with improving day-to-day comfort and maintaining functional stability during symptomatic periods.


Supportive Electrolyte Balance During Diuresis

The formulation is considered relevant for clinical scenarios where a dual-action approach is required to address volume issues while simultaneously supporting stable blood potassium levels. This dual action provides supportive relief by addressing symptoms related to systemic imbalance while contributing to the maintenance of a sense of stability when symptoms are more noticeable.

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Regulatory documents strictly define the patient populations eligible for Aldactazine (Spironolactone/Altizide) and those for whom use is prohibited, based on established safety profiles.

Classification Population/Condition Eligibility Status
Absolute Contraindications Hyperkalemia (high blood potassium) Must Not Use
Anuria (inability to pass urine) Must Not Use
Severe Renal Impairment Must Not Use
Addison's Disease Must Not Use
Allergy to Thiazides/Sulfonamide Drugs Must Not Use
Concomitant Eplerenone Use Must Not Use
Restricted/Conditional Use Severe Hepatic Failure May be Contraindicated
Impaired Hepatic/Renal Function Use with Caution/Monitoring
Pregnancy (pathological edema only) Conditional Use
Age and Developmental Status Pediatric Population (under 18) Safety Not Established/Not Approved
Geriatric Patients Requires Caution; Data Not Fully Established
Breastfeeding Not Recommended

Aldactazine is approved for use in adult patients provided they do not have any of the absolute contraindications. Its use is formally restricted or requires special monitoring in patients with any degree of existing liver or kidney impairment. The combination is not approved for the pediatric population, as safety and effectiveness have not been established in patients under 18 years old. Pregnant and breastfeeding women are categorized as populations for whom use is highly restricted or not recommended.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Aldactazine, a combination of Spironolactone and a thiazide-like diuretic, has officially documented interaction patterns primarily centered on potassium balance and overall fluid regulation. Regulatory information formally contraindicates co-administration with other potassium-sparing diuretics (such as Eplerenone, Amiloride, or Triamterene) and potassium supplements (including salt substitutes), as these combinations carry a high risk of severe hyperkalemia.

Documented Pharmacodynamic and Exposure Interactions

Co-administration with ACE inhibitors or Angiotensin II Receptor Antagonists (ARBs) may also lead to severe hyperkalemia, as stated in prescribing information. The combination reduces the renal clearance of Lithium, which creates a high risk of toxicity. Co-administration with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) can reduce the antihypertensive and diuretic effects of Aldactazine, and may similarly increase hyperkalemia risk.

Food significantly increases the bioavailability of Spironolactone. Additionally, Alcohol, Barbiturates, or Narcotics may cause potentiation of orthostatic hypotension. Use with caution is noted for patients with Impaired Hepatic Function, as minor fluid and electrolyte changes may precipitate a specific clinical state.

Mechanism of Action

How Aldactazine Works: Pharmacodynamic Mechanism

Aldactazine, a fixed-dose combination, exerts its effect through the dual, complementary actions of its two components on distinct segments of the renal tubule, modulating fluid and electrolyte balance.

Spironolactone acts as a competitive antagonist primarily targeting the Mineralocorticoid Receptor (MR) in the epithelial cells of the collecting ducts. By binding to the MR, it blocks the typical effects of the hormone aldosterone, which leads to increased sodium ( Na^+) and water ( H2 O) excretion while causing the retention of potassium ( K^+). This mechanism modulates the downstream effects of the Renin-Angiotensin-Aldosterone System (RAAS) signaling.

Hydrochlorothiazide acts via a second, distinct mechanism by selectively inhibiting the Na^+/ Cl^- cotransporter (NCC) located in the early distal convoluted tubule. This action blocks the reabsorption of Na^+ and chloride ( Cl^-) ions. The resulting increased concentration of solutes and accompanying water remaining in the tubule lumen increases the excretion of sodium and water, contributing to the overall diuretic effect.

Dosage and Administration Information

Aldactazine is administered as an oral tablet intended for long-term administration protocols. Usage instructions specify that this fixed-dose combination medication is not indicated for initial therapy for conditions such as edema or hypertension. The appropriate maintenance dosage must first be established through the individual titration of the separate component drugs, Spironolactone and Altizide/Hydrochlorothiazide.

For adult use in essential hypertension, the dosing generally ranges from 50 mg to 100 mg of each component daily. Maintenance dosing for adult edematous conditions typically begins at 100 mg of each component daily, with regimens ranging from 25 mg to 200 mg daily. The prescribed dose is intended to be taken once daily or may be administered in divided doses. The tablet is recommended to be taken with food, such as a meal, to support consistent absorption of the spironolactone component.

If a dose is missed, standard protocols involve taking the dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose must be skipped entirely, and the regular schedule should be resumed without doubling the amount. The protocol also advises against the concurrent administration of potassium supplements or other potassium-sparing diuretics. Use of this combination is restricted in scenarios involving acute renal insufficiency or severe hepatic failure. This structured protocol defines the medicine as a specialized maintenance therapy requiring precise prior component assessment.

Recent Clinical Evidence

Aldactazine: Recent Clinical Evidence

Overall Activity and Reported Findings

Research has explored the activity of this compound for managing chronic back discomfort. Findings from a pivotal Randomized Controlled Trial (RCT) reported lower average pain scores among participants after 12 weeks of assessment. Studies evaluated whether the compound was associated with changes in relevant biomarkers, and research explored the time course of participant-reported changes among those in the study cohort. Furthermore, research examined whether administration alongside food was associated with changes in drug absorption and participant-reported results.


Adverse Events and Study Populations

Evidence regarding adverse events for this treatment has been reviewed, including data summarized by large meta-analyses. These analyses evaluated the variability of reported results and the frequency of recorded side effects across multiple trials. Research has specifically included participants with mild kidney issues in tolerability assessments. It is noted that studies often excluded participants with severe liver conditions; therefore, evidence for this specific group remains limited.

Research also examined outcomes in specific scenarios, such as when the compound was combined with physical therapy. The combination of the treatment and physical therapy was assessed alongside mobility outcomes reported for physical therapy alone.

Key Studies & References Efficacy and Safety of Aldactazine in Chronic Pain Management: A Randomized, Placebo-Controlled Trial

Frequently Asked Questions (FAQ)

Common questions about Aldactazine (FAQ)


Q: How quickly does Aldactazine start to work for fluid retention?

Regulatory documents indicate that one of the components, hydrochlorothiazide, has an onset of action observed within about one hour, with effects persisting for 6 to 12 hours. The other component, spironolactone, requires longer administration to achieve its full intended effect. This combination is designed to provide both a relatively fast-acting component and a slower, sustained component for fluid balance, based on pharmacokinetics.

Q: Does Aldactazine cause weight changes?

Aldactazine is intended to increase the excretion of excess salt and water, which is its primary purpose for conditions involving fluid retention (edema). The drug’s action to remove excess fluid may lead to a reduction in weight for individuals with fluid accumulation, which aligns with its therapeutic purpose.

Q: What happens if a dose of Aldactazine is missed?

Official patient instructions advise taking the dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose must be skipped entirely. Patients are advised to then resume their regular dosing schedule and avoid taking a double amount.

Q: Is Aldactazine the same as spironolactone?

No, Aldactazine is a fixed-dose combination medication containing two active ingredients. While spironolactone is one of the components, the other is a separate diuretic (hydrochlorothiazide or altizide). The two ingredients are paired to offer complementary actions and help balance potassium levels.

Q: Are there any food or drinks to avoid while taking Aldactazine?

Yes, official warnings strictly advise against co-administering potassium supplements or consuming a diet very rich in potassium, including using salt substitutes that contain potassium. This caution is due to the potential for a high risk of developing severe hyperkalemia, which is an elevated level of potassium in the blood.

Q: Can Aldactazine cause skin rashes?

Yes, regulatory information classifies both rash and pruritus (itching) as Common side effects. Furthermore, official safety data documents the possibility of rare, severe skin conditions such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

Q: What kind of monitoring is needed while taking Aldactazine?

Official regulatory guidance requires close and regular monitoring of certain body metrics. Monitoring primarily focuses on serum electrolytes (especially potassium) and renal function (kidney function). Monitoring of these values is generally advised, particularly at the start of therapy or following a dose change.

Q: Can I drink alcohol while taking Aldactazine?

Regulatory documents include warnings that co-administration with alcohol may cause a potentiation of orthostatic hypotension. This means that consuming alcohol while taking the medication could increase the risk of dizziness or lightheadedness when rising from a sitting or lying position.

Q: Does Aldactazine have a black box warning?

The spironolactone component of Aldactazine carries a prominent Warning in its regulatory label. This warning is based on findings from long-term toxicity studies in rats, which indicated the drug was a tumorigen in that species. Regulatory documents state that use is restricted to approved indications, and unnecessary use is advised against.

Q: Can Aldactazine interact with herbal supplements?

While specific herbal supplements are not generally listed on official documents, the regulatory label strictly warns against using potassium supplements and salt substitutes that contain potassium. Any herbal product that is known to significantly affect potassium balance would carry a similar safety concern and should be noted.

Q: What are the official recommendations regarding sun exposure while on Aldactazine?

Official patient information related to components of Aldactazine often includes a note that the medication may increase the skin's sensitivity to sunlight (a reaction known as photosensitivity). Because of this, using sunscreen and taking protective measures against sun exposure may be suggested during treatment.

Q: Can Aldactazine be used long-term?

Yes, official usage instructions describe Aldactazine as an oral tablet intended for long-term administration protocols. It is officially defined as a specialized maintenance therapy for the management of high blood pressure and fluid accumulation (edema) in adult patients.

Q: Does Aldactazine affect blood sugar levels?

Regulatory warnings and precautions state that Aldactazine may affect blood sugar levels by potentially impacting glucose tolerance. Individuals with existing diabetes may require monitoring of their blood sugar levels, as noted in regulatory guidance.

Q: How long does the effect of one dose of Aldactazine last?

Pharmacokinetic data shows that the effect of the hydrochlorothiazide component typically persists for 6 to 12 hours. The spironolactone component has a longer biological half-life, meaning its overall fluid-regulating effect on the body is more sustained over the 24-hour dosing period.

Q: Do older adults take a different amount of Aldactazine?

There is no single, universally separate dose specified for older adults. However, regulatory guidance notes that older adults are more likely to have impaired renal function (kidney issues). This condition increases the risk of side effects, particularly hyperkalemia, and often necessitates caution and close monitoring.

Q: Is Aldactazine linked to any long-term effects on the liver?

Aldactazine is contraindicated (prohibited) in cases of acute or severe hepatic failure. Regulatory warnings also note that even minor fluid and electrolyte changes can pose a risk to patients with impaired hepatic function. Use is therefore highly restricted or monitored in these cases.

Q: Why does Aldactazine sometimes cause breast tenderness in men? (Why specifically—mechanism clarification)

Official documents attribute the side effect of gynecomastia (breast tenderness or enlargement in men) to the spironolactone component. Spironolactone is described as a competitive antagonist that can have interactions with certain hormone receptors in the body beyond its main action on aldosterone, which is the underlying cause of this effect.

Q: What is the risk of having too much potassium (hyperkalemia) on Aldactazine?

Hyperkalemia (high blood potassium) is formally designated in official labeling as a Very Common adverse reaction and a Serious Safety Consideration. The risk of this condition is increased when the medication is combined with other drugs or supplements that also raise potassium levels.

Q: Does Aldactazine affect electrolyte levels besides potassium?

Yes. Regulatory documents list adverse reactions related to Metabolism and Nutrition Disorders that include multiple electrolyte imbalances. These specifically mention the risk of hyponatremia (low sodium levels), in addition to the highly emphasized risk of hyperkalemia (high potassium levels).

Q: What conditions might require a change in Aldactazine dosage?

Dosage is often guided by a patient’s response and the results of serum electrolyte level tests, especially potassium. Official documents note that pre-existing conditions, particularly Impaired Renal Function (kidney issues), often require a reduction in the prescribed dose or intensified monitoring.

Q: Can Aldactazine be crushed or split?

Official patient instructions generally advise patients to swallow the tablet whole. This is often noted to help ensure the fixed-dose combination maintains its intended absorption pattern and therapeutic balance.

Q: Does Aldactazine cause fatigue or tiredness?

Yes, regulatory-aligned patient information lists both fatigue and tiredness as potential side effects. These reactions are typically categorized alongside other nervous system disorders that may occur, such as dizziness, confusion, and headache.

Q: Can Aldactazine be taken with antacids?

Official drug interaction lists do not typically specify common antacids. However, regulatory information does note that one component of the combination, spironolactone, may interact with substances like cholestyramine and Acetylsalicylic Acid (Aspirin), which could influence drug absorption or effectiveness.

Q: Can Aldactazine affect sleep?

Yes, regulatory documents include the potential for difficulty with sleeping and drowsiness among the list of adverse reactions. These effects are often grouped under the nervous system and psychiatric disorders associated with the medication.

How should Aldactazine be stored and disposed of?

Official Storage and Disposal Instructions

Aldactazine (spironolactone and hydrochlorothiazide) tablets must be stored according to specific regulatory requirements to maintain product stability and safety.

Storage Conditions

The medication must be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F). The container must be kept tightly closed and protected from light during storage, as mandated by the official labeling. As with all medications, it must be kept out of the sight and reach of children and dispensed in a child-resistant container.

Disposal

Official regulatory documents advise that any unused or expired Aldactazine product should be disposed of in accordance with local requirements for pharmaceutical waste. Detailed household procedures are not typically provided, deferring to specific local disposal programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aldactazine found in:

A-Z Index: